BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Analogic Corporation (ALOG)'s COBRA Checkpoint CT System Receives ACBX Approval From the United Kingdom Department for Transport


7/18/2013 8:41:00 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Analogic's COBRA Checkpoint CT System Receives ACBX Approval From the United Kingdom Department for Transport

PEABODY, Mass., July 18, 2013 (GLOBE NEWSWIRE) -- Analogic Corporation (ALOG), enabling the world's medical imaging and aviation security technology, today announced that its COBRA(R) checkpoint computed tomography (CT) system has been approved by the United Kingdom's Department for Transport (DfT) as an Advanced Cabin Baggage X-ray (ACBX) system. The ACBX approval is in addition to the COBRA's existing approvals by the European Civil Aviation Conference (ECAC) and U.S. Transportation Security Administration (TSA). In March 2013, the COBRA checkpoint CT system became the only system to meet the Standard 2 detection level in Type D operations, where liquids, aerosols and gels (LAGs) remain inside passenger carry-on bags, and Type D+ operations, where LAGs and complex electronics, such as laptops, remain inside passenger carry-on bags.

Jim Green, Analogic's president and CEO, commented, "The ACBX approval, combined with the previously announced ECAC approval, paves the way for operational testing at Europe's largest airports. We believe that CT technology is the future of the checkpoint, resulting in increased passenger throughput, enhanced detection of explosives and other threats, and an improved passenger experience, while allowing liquids and laptops to remain in carry-on bags, ultimately reducing airport operating costs."

Eric Zanin, vice president and general manager for the Security business, said, "We recognize the significance of the DfT approval and are proud to have the COBRA added to the list of approved ACBX systems. Our COBRA checkpoint CT system delivers best-in-class threat detection performance with higher passenger throughput for the UK and other international airports."

Analogic's CT technology meets the highest TSA, ECAC, and DfT standards for threat detection. Over the past fifteen years, Analogic has developed and deployed more than 1,200 state-of-the-art threat detection systems and subsystems for use in airports around the world. Analogic provides innovative solutions for a wide spectrum of customers ranging from small regional airports to large international hubs.

About Analogic

Analogic (ALOG) provides leading-edge healthcare and security technology solutions to advance the practice of medicine and save lives. We are recognized around the world for advanced imaging systems and technology that enable computed tomography, ultrasound, digital mammography, and magnetic resonance imaging (MRI), as well as automated threat detection for aviation security. Our CT, MRI, digital mammography, and ultrasound transducer products are sold to original equipment manufacturers (OEMs), providing state-of-the-art capability and enabling them to enter new markets and expand their existing market presence. Our market-leading BK Medical and Ultrasonix branded ultrasound systems, used in procedure-driven markets such as urology, surgery, and point-of-care, are sold to clinical end users through our direct sales force. For over 40 years we've enabled customers to thrive, improving the health and enhancing the safety of people around the world. Analogic is headquartered just north of Boston, Massachusetts. For more information, visit www.analogic.com.

Analogic and COBRA are registered trademarks of Analogic Corporation.

The globe logo is a trademark of Analogic Corporation.

Contact:

Investor Contact:

Mark Namaroff

Director of Investor Relations

(978) 326-4058

investorrelations@analogic.com

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES